Illumina (ILMN) Operating Margin (2009 - 2026)
Illumina (ILMN) operating margin from Jun 28, 2009 to Mar 29, 2026. The current Illumina (ILMN) operating margin is 19.16%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Operating Margin
Quarterly Operating Margin
Annual Operating Margin change of Illumina (ILMN)
| Year | Operating Margin | Change |
|---|---|---|
| 2025 | 18.58% | -197.53% |
| 2024 | -19.05% | -19.72% |
| 2023 | -23.73% | -73.97% |
| 2023 | -91.16% | +3254.57% |
| 2022 | -2.72% | -115.18% |
| 2021 | 17.91% | -35.59% |
| 2019 | 27.80% | +4.94% |
| 2018 | 26.49% | N/A |
| 2018 | 0.00% | N/A |
| 2018 | 0.00% | N/A |
| 2018 | 0.00% | -100.00% |
| 2017 | 22.02% | N/A |
| 2017 | 0.00% | N/A |
| 2017 | 0.00% | N/A |
| 2017 | 0.00% | -100.00% |
| 2017 | 24.48% | N/A |
| 2016 | 0.00% | N/A |
| 2016 | 0.00% | N/A |
| 2016 | 0.00% | -100.00% |
| 2016 | 27.61% | N/A |
| 2015 | 0.00% | N/A |
| 2015 | 0.00% | N/A |
| 2015 | 0.00% | -100.00% |
| 2014 | 27.65% | N/A |
| 2014 | 0.00% | N/A |
| 2014 | 0.00% | N/A |
| 2014 | 0.00% | -100.00% |
| 2013 | 9.44% | N/A |
| 2013 | 0.00% | N/A |
| 2013 | 0.00% | N/A |
| 2013 | 0.00% | -100.00% |
| 2012 | 17.48% | N/A |
| 2012 | 0.00% | N/A |
| 2012 | 0.00% | N/A |
| 2012 | 0.00% | -100.00% |
| 2012 | 18.90% | N/A |
| 2011 | 0.00% | N/A |
| 2011 | 0.00% | N/A |
| 2011 | 0.00% | -100.00% |
| 2011 | 23.45% | N/A |
| 2010 | 0.00% | N/A |
| 2010 | 0.00% | N/A |
| 2010 | 0.00% | -100.00% |
| 2010 | 18.85% | +34.29% |
| 2008 | 14.04% | N/A |
Comparison Illumina (ILMN) operating margin with competitors
Illumina (ILMN) operating margin is 19.16%.
| Ticker | Name | Operating Margin | Upside |
|---|---|---|---|
| IDXX | Idexx Laboratories Inc | 31.78% | +65.89% |
| SHC | Sotera Health Company | 28.16% | +47.00% |
| MTD | Mettler-Toledo International Inc | 26.00% | +35.72% |
| DHR | Danaher Corp | 22.58% | +17.87% |
| QGEN | Qiagen NV | 22.29% | +16.36% |
| MEDP | Medpace Holdings Inc | 20.03% | +4.56% |
| A | Agilent Technologies Inc | 19.63% | +2.47% |
| TMO | Thermo Fisher Scientific Inc | 16.93% | -11.62% |
| BLLN | Billiontoone Inc - Class A | 16.45% | -14.13% |
| VCYT | Veracyte Inc | 16.28% | -15.02% |
| DGX | Quest Diagnostics Inc | 13.78% | -28.07% |
| IQV | IQVIA Holdings Inc | 12.38% | -35.38% |
| CRL | Charles River Laboratories International Inc | 12.04% | -37.15% |
| LH | Laboratory Corp Of America Holdings | 10.76% | -43.83% |
| RVTY | Revvity Inc | 10.67% | -44.30% |
| ICLR | Icon Plc | 5.37% | -71.97% |
| CDNA | Caredx Inc | 1.02% | -94.68% |